Related references
Note: Only part of the references are listed.Mechanisms of resistance to chemotherapy in non-small cell lung cancer
Hye-Young Min et al.
ARCHIVES OF PHARMACAL RESEARCH (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
Jin Gao et al.
CANCER CELL INTERNATIONAL (2020)
EMT-inducing transcription factor ZEB1-associated resistance to the BCL-2/BCL-XL inhibitor is overcome by BIM upregulation in ovarian clear cell carcinoma cells
Akane Inoue-Yamauchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Pharmacological effects of harmine and its derivatives: a review
Liang Zhang et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
Zachary A. Yochum et al.
ONCOGENE (2019)
Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
Wei Lu et al.
DEVELOPMENTAL CELL (2019)
lncRNA ZEB1-AS1 promotes migration and metastasis of bladder cancer cells by post-transcriptional activation of ZEB1
Xin Zhao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
Epithelial-to-mesenchymal transition and drug resistance: transitioning away from death
Kyung-A Song et al.
JOURNAL OF THORACIC DISEASE (2019)
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
Chenjing Zhu et al.
MOLECULAR CANCER (2019)
Therapeutic implications of cancer epithelial-mesenchymal transition (EMT)
Eunae Sandra Cho et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
TWIST1 GENE EXPRESSION AS A BIOMARKER FOR PREDICTING PRIMARY DOXORUBICIN RESISTANCE IN BREAST CANCER
S. Demir et al.
BALKAN JOURNAL OF MEDICAL GENETICS (2019)
Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT
Rong Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
Xiang Zhang et al.
CELL DEATH & DISEASE (2018)
A landscape view on the interplay between EMT and cancer metastasis
Chunhe Li et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2018)
Snail-Induced Epithelial-to-Mesenchymal Transition Enhances P-gp-Mediated Multidrug Resistance in HCC827 Cells
Takumi Tomono et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer
Wenjing Su et al.
MOLECULAR CANCER (2017)
A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer
Zachary A. Yochum et al.
MOLECULAR CANCER RESEARCH (2017)
Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation
Yadi Wu et al.
NATURE COMMUNICATIONS (2017)
Twist1 confers multidrug resistance in colon cancer through upregulation of ATP-binding cassette transporters
Yan-Rong Liu et al.
ONCOTARGET (2017)
ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC
Darina Lazarova et al.
JOURNAL OF CANCER (2017)
ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells
Cao Guo et al.
JOURNAL OF CANCER (2017)
Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition
George E. Duran et al.
BRITISH JOURNAL OF CANCER (2017)
Relationship Between Increased Expression of the Axl/Gas6 Signal Cascade and Prognosis of Patients with Upper Tract Urothelial Carcinoma
Seiya Hattori et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
X. Zhu et al.
ONCOGENE (2016)
被撤回的出版物: Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma (Retracted article. See vol. 41, pg. 4839, 2022)
T. Li et al.
ONCOGENE (2016)
Twist mediates an aggressive phenotype in human colorectal cancer cells
Jun-Jian Deng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Phosphorylation Regulates Functions of ZEB1 Transcription Factor
M. Candelaria Llorens et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
Silvia Juliana Serrano-Gomez et al.
MOLECULAR CANCER (2016)
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Bowen Du et al.
MOLECULES (2016)
Gas6/Axl Axis Contributes to Chemoresistance and Metastasis in Breast Cancer through Akt/GSK-3 beta/beta-catenin Signaling
Cun Wang et al.
THERANOSTICS (2016)
Role of EMT in Metastasis and Therapy Resistance
Bethany N. Smith et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Glycosylation in Cancer: interplay between Multidrug Resistance and epithelial-to-Mesenchymal Transition?
Leonardo Marques da Fonseca et al.
FRONTIERS IN ONCOLOGY (2016)
ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
Takeshi Yoshida et al.
PLOS ONE (2016)
TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
Cai M. Roberts et al.
SCIENTIFIC REPORTS (2016)
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
Tsz-Lun Yeung et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Multiple Drug Transport Pathways through Human P-Glycoprotein
James W. McCormick et al.
BIOCHEMISTRY (2015)
Targeted Inhibition of Snail Activity in Breast Cancer Cells by Using a CoIII-Ebox Conjugate
Luke F. Vistain et al.
CHEMBIOCHEM (2015)
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
Toni M. Brand et al.
CLINICAL CANCER RESEARCH (2015)
Axl Activates Autocrine Transforming Growth Factor-β Signaling in Hepatocellular Carcinoma
Patrick Reichl et al.
HEPATOLOGY (2015)
Transforming growth factor-1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells
Lingmei Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Elevated STAT3 Signaling-Mediated Upregulation of MMP-2/9 Confers Enhanced Invasion Ability in Multidrug-Resistant Breast Cancer Cells
Fei Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness
Wareeporn Wattanawongdon et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression
Germano Mariano et al.
ONCOTARGET (2015)
P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells
Fei Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance
Paraskevi Mallini et al.
CANCER TREATMENT REVIEWS (2014)
Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma
Hsin-Jung Lee et al.
CARCINOGENESIS (2014)
AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer
Philip D. Dunne et al.
CLINICAL CANCER RESEARCH (2014)
MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis
Chi-Hong Chao et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells
Sumei Lu et al.
MOLECULAR MEDICINE REPORTS (2014)
Oncogenic roles of EMT-inducing transcription factors
Alain Puisieux et al.
NATURE CELL BIOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Targeting EMT in cancer: opportunities for pharmacological intervention
Felicity M. Davis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition
Catherine Wilson et al.
ONCOTARGET (2014)
EMT or EMT-promoting transcription factors, where to focus the light?
Stephane Ansieau et al.
FRONTIERS IN ONCOLOGY (2014)
ZEB1 Promotes Invasiveness of Colorectal Carcinoma Cells through the Opposing Regulation of uPA and PAI-1
Ester Sanchez-Tillo et al.
CLINICAL CANCER RESEARCH (2013)
miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling
Yong Chen et al.
MOLECULAR MEDICINE REPORTS (2013)
The Snail Family Gene Snai3 Is Not Essential for Embryogenesis in Mice
Cara K. Bradley et al.
PLOS ONE (2013)
Intrinsic and Acquired Drug Resistance in Malignant Tumors
Theodor Lippert et al.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH (2012)
Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells
Weijia Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
Alexandria M. Haslehurst et al.
BMC CANCER (2012)
Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)
Cristina Oliveras-Ferraros et al.
CELL CYCLE (2012)
Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms
Qian Qin et al.
CELL RESEARCH (2012)
Twist Confers Chemoresistance to Anthracyclines in Bladder Cancer through Upregulating P-Glycoprotein
Yule Chen et al.
CHEMOTHERAPY (2012)
Characterization of the SNAG and SLUG Domains of Snail2 in the Repression of E-Cadherin and EMT Induction: Modulation by Serine 4 Phosphorylation
Patricia Molina-Ortiz et al.
PLOS ONE (2012)
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
Ding-Wu Shen et al.
PHARMACOLOGICAL REVIEWS (2012)
Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells
Weijia Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)
Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Tzu-Hua Chang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern
Ozlem Darcansoy Iseri et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells
Masaki Shiota et al.
BJU INTERNATIONAL (2011)
Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters
Junlin Li et al.
BMC CANCER (2011)
Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non-Small-Cell Lung Cancer
Takayuki Kosaka et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Androgen Receptor Regulates Transcription of the ZEB1 Transcription Factor
Bynthia M. Anose et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2011)
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
M. Saxena et al.
CELL DEATH & DISEASE (2011)
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
J. Hao et al.
BRITISH JOURNAL OF CANCER (2010)
Regulation of Excision Repair Cross-Complementation Group 1 by Snail Contributes to Cisplatin Resistance in Head and Neck Cancer
Dennis Shin-Shian Hsu et al.
CLINICAL CANCER RESEARCH (2010)
E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells
Volodymyr P. Tryndyak et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells
S-H Lee et al.
ONCOGENE (2010)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
Qing-Quan Li et al.
CLINICAL CANCER RESEARCH (2009)
Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites
Sairei So et al.
JOURNAL OF CELL BIOLOGY (2009)
Role of Matrix Metalloproteinases in Epithelial Migration
Peter Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line
Jin Kyung Rho et al.
LUNG CANCER (2009)
Cancer stem cells: mirage or reality?
Piyush B. Gupta et al.
NATURE MEDICINE (2009)
Evolutionary history of the Snail/Scratch superfamily
Alejandro Barrallo-Gimeno et al.
TRENDS IN GENETICS (2009)
Blocking of p53-Snail Binding, Promoted by Oncogenic K-Ras, Recovers p53 Expression and Function
Sun-Hye Lee et al.
NEOPLASIA (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway
Wen-Lei Zhuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence
Stephane Ansieau et al.
CANCER CELL (2008)
Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells
Hui Xing et al.
CANCER LETTERS (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function
George Z. Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Direct regulation of TWIST by HIF-1α promotes metastasis
Muh-Hwa Yang et al.
NATURE CELL BIOLOGY (2008)
Fibronectin-mediated activation of Akt2 protects human ovarian and breast cancer cells from docetaxel-induced apoptosis via inhibition of the p38 pathway
Hui Xing et al.
APOPTOSIS (2008)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel
George Z. Cheng et al.
CANCER RESEARCH (2007)
Tumor metastasis: mechanistic insights and clinical challenges
Patricia S. Steeg
NATURE MEDICINE (2006)
Alternating current electrical stimulation enhanced chemotherapy: a novel strategy to bypass multidrug resistance in tumor cells
D Janigro et al.
BMC CANCER (2006)
Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines
SE Witta et al.
CANCER RESEARCH (2006)
Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition
S Thomson et al.
CANCER RESEARCH (2005)
The Snail genes as inducers of cell movement and survival: implications in development and cancer
A Barrallo-Gimeno et al.
DEVELOPMENT (2005)
Signaling through the epidermal growth factor receptor during the development of malignancy
JR Grandis et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells
XH Wang et al.
ONCOGENE (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Epithelial-mesenchymal transition and its implications for fibrosis
R Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Metastatic ovarian tumors: a review of 64 cases
N Yada-Hashimoto et al.
GYNECOLOGIC ONCOLOGY (2003)
Epithelial-mesenchymal transitions in development and pathologies
JP Thiery
CURRENT OPINION IN CELL BIOLOGY (2003)
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E Batlle et al.
NATURE CELL BIOLOGY (2000)
Share Paper
